Look here for a clue. There's no foolproof way to know the future for Syneron Medical (Nasdaq: ELOS) or any other company. However, certain clues may help you see potential stumbles before they happen ...
Syneron Medical (Nasdaq: ELOS) reported earnings on Feb. 9. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Dec. 31 (Q4), Syneron Medical missed estimates on ...
Syneron Medical Ltd. and Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company Combination of Syneron and Candela creates the most comprehensive aesthetic device product ...
IRVINE, Calif. and LONDON, April 3, 2017 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, and Apax Partners, a leading global private equity ...
YOKNEAM, ISRAEL -- (MARKET WIRE) -- 11/10/2008 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos TM combined-energy medical aesthetic devices, today ...
IRVINE, Calif.--(BUSINESS WIRE)--Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, today announced the successful completion of its acquisition by an ...
BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader ...
BEIJING, Dec. 18, 2025 /PRNewswire/ -- Syneron Bio, an macrocyclic peptide drug discovery company driven by intelligent high-throughput platform, has successfully completed its Series A and A+ ...
WATERTOWN, MA and ZIJTAART, THE NETHERLANDS--(Marketwired - May 30, 2014) - Exergen Global, the worldwide value added supplier and solutions provider of Exergen's corporate line of infrared, ...
In this series, we measure how swiftly a company turns cash into goods or services and back into cash. We'll use a quick, relatively foolproof tool known as the cash conversion cycle, or CCC for short ...
IRVINE, Calif., May 10, 2017 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS) today announced the expiration of the 37-day "go-shop" period under the terms of the previously announced merger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results